These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 39238030)

  • 41. In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders.
    Maeda J; Zhang MR; Okauchi T; Ji B; Ono M; Hattori S; Kumata K; Iwata N; Saido TC; Trojanowski JQ; Lee VM; Staufenbiel M; Tomiyama T; Mori H; Fukumura T; Suhara T; Higuchi M
    J Neurosci; 2011 Mar; 31(12):4720-30. PubMed ID: 21430171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
    Fan Z; Okello AA; Brooks DJ; Edison P
    Brain; 2015 Dec; 138(Pt 12):3685-98. PubMed ID: 26510952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.
    Kreisl WC; Lyoo CH; McGwier M; Snow J; Jenko KJ; Kimura N; Corona W; Morse CL; Zoghbi SS; Pike VW; McMahon FJ; Turner RS; Innis RB;
    Brain; 2013 Jul; 136(Pt 7):2228-38. PubMed ID: 23775979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis.
    Bradburn S; Murgatroyd C; Ray N
    Ageing Res Rev; 2019 Mar; 50():1-8. PubMed ID: 30610927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study.
    Brendel M; Probst F; Jaworska A; Overhoff F; Korzhova V; Albert NL; Beck R; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Kleinberger G; Haass C; Herms J; Rominger A
    J Nucl Med; 2016 Jun; 57(6):954-60. PubMed ID: 26912428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PET Imaging to Measure Neuroinflammation In Vivo.
    Malpetti M; Franzmeier N; Brendel M
    Methods Mol Biol; 2024; 2785():177-193. PubMed ID: 38427195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. From positron emission tomography to cell analysis of the 18-kDa Translocator Protein in mild traumatic brain injury.
    Delage C; Vignal N; Guerin C; Taib T; Barboteau C; Mamma C; Khacef K; Margaill I; Sarda-Mantel L; Rizzo-Padoin N; Hontonnou F; Marchand-Leroux C; Lerouet D; Hosten B; Besson V
    Sci Rep; 2021 Dec; 11(1):24009. PubMed ID: 34907268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein.
    Lyoo CH; Ikawa M; Liow JS; Zoghbi SS; Morse CL; Pike VW; Fujita M; Innis RB; Kreisl WC
    J Nucl Med; 2015 May; 56(5):701-6. PubMed ID: 25766898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.
    El Gaamouch F; Audrain M; Lin WJ; Beckmann N; Jiang C; Hariharan S; Heeger PS; Schadt EE; Gandy S; Ehrlich ME; Salton SR
    Mol Neurodegener; 2020 Jan; 15(1):4. PubMed ID: 31924226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amyloid load and translocator protein 18 kDa in APPswePS1-dE9 mice: a longitudinal study.
    Sérrière S; Tauber C; Vercouillie J; Mothes C; Pruckner C; Guilloteau D; Kassiou M; Doméné A; Garreau L; Page G; Chalon S
    Neurobiol Aging; 2015 Apr; 36(4):1639-1652. PubMed ID: 25680265
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microglial Activation in the Retina of a Triple-Transgenic Alzheimer's Disease Mouse Model (3xTg-AD).
    Salobrar-García E; Rodrigues-Neves AC; Ramírez AI; de Hoz R; Fernández-Albarral JA; López-Cuenca I; Ramírez JM; Ambrósio AF; Salazar JJ
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease.
    Hamelin L; Lagarde J; Dorothée G; Potier MC; Corlier F; Kuhnast B; Caillé F; Dubois B; Fillon L; Chupin M; Bottlaender M; Sarazin M
    Brain; 2018 Jun; 141(6):1855-1870. PubMed ID: 29608645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TSPO and amyloid deposits in sub-regions of the hippocampus in the 3xTgAD mouse model of Alzheimer's disease.
    Tournier BB; Tsartsalis S; Rigaud D; Fossey C; Cailly T; Fabis F; Pham T; Grégoire MC; Kövari E; Moulin-Sallanon M; Savioz A; Millet P
    Neurobiol Dis; 2019 Jan; 121():95-105. PubMed ID: 30261283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The mitochondrial protein TSPO in Alzheimer's disease: relation to the severity of AD pathology and the neuroinflammatory environment.
    Garland EF; Dennett O; Lau LC; Chatelet DS; Bottlaender M; Nicoll JAR; Boche D
    J Neuroinflammation; 2023 Aug; 20(1):186. PubMed ID: 37580767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
    Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.
    Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease.
    Song M; Jin J; Lim JE; Kou J; Pattanayak A; Rehman JA; Kim HD; Tahara K; Lalonde R; Fukuchi K
    J Neuroinflammation; 2011 Aug; 8():92. PubMed ID: 21827663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease.
    Janssen B; Mach RH
    Prog Mol Biol Transl Sci; 2019; 165():371-399. PubMed ID: 31481170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
    Simmons DA; James ML; Belichenko NP; Semaan S; Condon C; Kuan J; Shuhendler AJ; Miao Z; Chin FT; Longo FM
    Hum Mol Genet; 2018 Aug; 27(16):2893-2912. PubMed ID: 29860333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.